Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium spirulan is a sulfated polysaccharide derived from the cyanobacterium Spirulina platensis. It is a water-soluble macromolecule, often isolated as its sodium salt, with reported biological activities including antiviral, anticoagulant, and immunomodulatory effects. Mechanistically, it is known to inhibit viral replication by interfering with viral entry and adsorption, and to exhibit anticoagulant effects by targeting components of the coagulation cascade. Sodium spirulan is primarily studied as a bioactive extract in laboratory settings and is not an approved pharmaceutical agent. It has been investigated as a potential ingredient in nutraceuticals, functional foods, and as a health supplement for its possible beneficial effects in oxidative stress and chronic inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium spirulan.